Safety and activity of nonpegylated liposomal doxorubicin (nPLD) combined with oral metronomic cyclophosphamide (mC) as preoperative treatment for locally advanced breast cancer (BC) patients (pts).

Daniele Andreis, Alberto Bottini, Chiara Foroni et al.|Journal of Clinical Oncology|2012

Cited by 0